Comparative characteristics of postoperative outcomes of different treatment strategies of patients with intermittent claudication in combination with coronary arteries disease

Aim      To compare in-hospital outcomes (severe cardiovascular complications, CVC) in patients with IIB stage chronic lower limb ischemia (CLLI) in combination with ischemic heart disease (IHD) in the following groups: stepwise percutaneous coronary intervention (PCI) and stenting and angioplasty of lower limb arteries (LLA) (group 1) and combination treatment, including PCI and open surgery on LLA (group 2).

Material and methods  Since 2019, the A.V. Vishnevsky National Medical Research Center of Surgery has performed a retrospective study that includes patients with stage IIB CLLI in combination with IHD. Patients were divided into 2 groups: group 1 (n=46), stepwise X-ray endovascular treatment (PCI and stenting and angioplasty of LLA); group 2 (n=46), stepwise combination treatment (PCI and open surgery on LLA). The endpoint included severe CVCs (death, acute myocardial infarction, acute cerebrovascular disease) and severe complications in the LLA area (stent thrombosis, repeated intervention on LLA, amputation).

Results In 198 surgeries, none of 92 patients had severe CVC, and no fatal outcomes were observed. In group 2, there was one (2.1 %) severe complication on LLA during the early postoperative period, for which a successful additional intervention was performed.

Conclusion      Individualized approach to care of each patient with LLA pathology in combination with IHD helps avoiding severe CVCs at the hospital stage. It was shown that X-ray endovascular and combination treatments are safe and effective in the absence of fatal outcomes and acute disorders of coronary circulation at the hospital stage.

1. Kullo IJ, Rooke TW. Peripheral Artery Disease. New England Journal of Medicine. 2016;374(9):861–71. DOI: 10.1056/NEJMcp1507631

2. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL et al. International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis. JAMA. 2006;295(2):180–9. DOI: 10.1001/jama.295.2.180

3. Sigvant B, Kragsterman B, Falkenberg M, Hasvold P, Johansson S, Thuresson M et al. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. Journal of Vascular Surgery. 2016;64(4):1009-1017.e3. DOI: 10.1016/j.jvs.2016.03.429

4. Matskeplishvili S, Kontsevaya A. Cardiovascular Health, Disease, and Care in Russia. Circulation. 2021;144(8):586–8. DOI: 10.1161/CIRCULATIONAHA.121.055239

5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Vascular Surgery. 2007;45(1):S5–67. DOI: 10.1016/j.jvs.2006.12.037

6. Aboyans V, Ricco J-B, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39(9):763–816. DOI: 10.1093/eurheartj/ehx095

7. Alekyan B.G., Pokrovsky A.V., Karapetyan N.G., Revishvili A.Sh. A multidisciplinary approach in determining of prevalence of coronary artery disease and treatment strategies in patients with pathology of the aorta and peripheral arteries. Russian Journal of Cardiology. 2019;24(8):8–16. DOI: 10.15829/1560-4071-2019-8-8-16

8. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-654. DOI: 10.1161/CIRCULATIONAHA.106.174526

9. Alekyan B.G., Grigoryan A.M., Staferov A.V., Karapetyan N.G. Endovascular diagnostics and treatment in the Russian federation (2018). Russian Journal of Endovascular Surgery. 2019;6(2 Special issue):S5–188. DOI: 10.24183/2409-4080-2018-5-2-93-240

10. Alekyan B.G., Grigoryan A.M., Staferov A.V., Karapetyan N.G. Endovascular diagnostics and treatment of diseases of the heart and blood vessels in the Russian Federation 2019. Russian Journal of Endovascular Surgery. 2020;7(2 Spec issue):S5–230. DOI: 10.24183/2409-4080-2020-7-2S-S5-S230

11. Alekyan B.G., Pokrovskiy A.V., Karapetyan N.G., Chupin A.V., Varava A.B., Knysh Yu.B. et al. Hospital results of endovascular treatment for combined lesions of intermittent claudication and coronary artery disease. Russian Journal of Endovascular Surgery. 2020;7(2):130–7. DOI: 10.24183/2409-4080-2020-7-2-130-137

12. Raghunathan A, Rapp JH, Littooy F, Santilli S, Krupski WC, Ward HB et al. Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: A subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial. Journal of Vascular Surgery. 2006;43(6):1175–82. DOI: 10.1016/j.jvs.2005.12.069

13. Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB et al. Systematic Strategy of Prophylactic Coronary Angiography Improves Long-Term Outcome After Major Vascular Surgery in Medium- to High-Risk Patients. Journal of the American College of Cardiology. 2009;54(11):989–96. DOI: 10.1016/j.jacc.2009.05.041

14. Nordanstig J, Taft C, Hensäter M, Perlander A, Österberg K, Jivegård L. Improved Quality of Life After 1 Year With an Invasive Versus a Noninvasive Treatment Strategy in Claudicants: One-Year Results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation. 2014;130(12):939–47. DOI: 10.1161/CIRCULATIONAHA.114.009867

15. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):686–725. DOI: 10.1161/CIR.0000000000000470

16. Tang Q-H, Chen J, Hu C-F, Zhang X-L. Comparison Between Endovascular and Open Surgery for the Treatment of Peripheral Artery Diseases: A Meta-Analysis. Annals of Vascular Surgery. 2020;62:484–95. DOI: 10.1016/j.avsg.2019.06.039

17. Olinic D-M, Spinu M, Olinic M, Homorodean C, Tataru D-A, Liew A et al. Epidemiology of peripheral artery disease in Europe: VAS Educational Paper. International Angiology. 2018;37(4):327–34. DOI: 10.23736/S0392-9590.18.03996-2